Neuren’s DAYBUE Gains Canadian Approval, Expanding Market
PremiumCompany AnnouncementsNeuren’s DAYBUE Gains Canadian Approval, Expanding Market
1M ago
Neuren Pharmaceuticals Advances PMS Treatment Trials
Premium
Company Announcements
Neuren Pharmaceuticals Advances PMS Treatment Trials
1M ago
Neuren Pharmaceuticals Sees Surge in H1 Revenue
Premium
Company Announcements
Neuren Pharmaceuticals Sees Surge in H1 Revenue
3M ago
Neuren’s Trial Suggests Breakthrough in Angelman Syndrome
PremiumCompany AnnouncementsNeuren’s Trial Suggests Breakthrough in Angelman Syndrome
3M ago
Neuren Pharmaceuticals Awaits Key Clinical Trial Results
Premium
Company Announcements
Neuren Pharmaceuticals Awaits Key Clinical Trial Results
3M ago
Neuren Pharma’s Q2 Growth and Clinical Advances
Premium
Company Announcements
Neuren Pharma’s Q2 Growth and Clinical Advances
3M ago
Neuren Pharmaceuticals Targets Neurodevelopmental Progress
PremiumCompany AnnouncementsNeuren Pharmaceuticals Targets Neurodevelopmental Progress
6M ago
Neuren Pharmaceuticals’ Lucrative Year with DAYBUE Success
Premium
Company Announcements
Neuren Pharmaceuticals’ Lucrative Year with DAYBUE Success
6M ago
Neuren Pharmaceuticals Reveals Promising Trial Results
Premium
Company Announcements
Neuren Pharmaceuticals Reveals Promising Trial Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100